Search

Your search keyword '"Sulima, Agnieszka"' showing total 237 results

Search Constraints

Start Over You searched for: Author "Sulima, Agnieszka" Remove constraint Author: "Sulima, Agnieszka"
237 results on '"Sulima, Agnieszka"'

Search Results

3. Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice

7. Impacts of Self-Administered 3,4-Methylenedioxypyrovalerone (MDPV) Alone, and in Combination with Caffeine, on Recognition Memory and Striatal Monoamine Neurochemistry in Male Sprague Dawley Rats: Comparisons with Methamphetamine and Cocaine

10. Potent MOR Agonists from 2′-Hydroxy-5,9-dimethyl-N-phenethyl Substituted-6,7-benzomorphans and from C8-Hydroxy, Methylene and Methyl Derivatives of N-Phenethylnormetazocine

19. Role of efficacy as a determinant of locomotor activation by mu‐opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR‐selective phenylmorphans with high‐to‐low MOR efficacy

20. Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphans

23. Opioid-related discriminative stimulus, antinociceptive and respiratory depressant effects of substituted 3-hydroxy-N-phenethyl-5-phenylmorphans

24. Efficacy As A Determinant Of Mu Opioid Receptor (MOR) Analgesic Effects In A Novel Assay Of Pain-Depressed Behavior In Mice. Ii. Effects Of Novel Low-Efficacy MOR Agonists

25. Initial Pharmacological Characterization of a Major Hydroxy Metabolite of PF-5190457:Inverse Agonist Activity of PF-6870961 at the Ghrelin Receptor

27. Initial Pharmacological Characterization of a Major Hydroxy Metabolite of PF-5190457: Inverse Agonist Activity of PF-6870961 at the Ghrelin Receptor

28. A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and Antagonists

31. Design, Synthesis, and In Vivo Evaluation of C1-Linked 4,5-Epoxymorphinan Haptens for Heroin Vaccines

32. Sex differences in the effect of chronic delivery of the buprenorphine analogue BU08028 on heroin relapse and choice in a rat model of opioid maintenance

33. Novel Dual-Target Mu Opioid (MOR) and Dopamine D(3) Receptors (D(3)R) Ligands as Potential Non-Addictive Pharmacotherapeutics for Pain Management

35. PHARMACOLOGICAL CHARACTERIZATION OF A GHRELIN RECEPTOR ANTAGONIST/ INVERSE AGONIST, PF-5190457, AND ITS MAJOR ACTIVE HYDROXY METABOLITE

38. Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management

44. Novel chimeric monoclonal antibodies that block fentanyl effects and alter fentanyl biodistribution in mice

45. Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice.

Catalog

Books, media, physical & digital resources